Literature DB >> 19009477

Clinical and psychological correlates of two domains of hopelessness in schizophrenia.

Paul H Lysaker1, Michelle P Salyers, Jack Tsai, Linda Yorkman Spurrier, Louanne W Davis.   

Abstract

Hopelessness is a widely observed barrier to recovery from schizophrenia spectrum disorders. Yet little is known about how clinical, social, and psychological factors independently affect hope. Additionally, the relationships that exist between these factors and different kinds of hope are unclear. To explore both issues, we correlated two aspects of hope, expectations of the future and agency, with stigma, clinical symptoms, anxiety, and coping preferences in 143 persons with a schizophrenia spectrum disorder. Multiple regressions revealed that hope for the future was predicted by lesser alienation, lesser preference for ignoring stressors, and lesser emotional discomfort and negative symptoms, accounting for 43% of the variance. A greater sense of agency was linked to lesser endorsement of mental illness stereotypes, fewer negative symptoms, lesser social phobia, and lesser preference for ignoring stressors, accounting for 44% of the variance. Implications for research and interventions are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 19009477     DOI: 10.1682/jrrd.2007.07.0108

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  10 in total

1.  Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping.

Authors:  Jack Tsai; Paul H Lysaker; Jenifer L Vohs
Journal:  J Ment Health       Date:  2010-04

Review 2.  The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis.

Authors:  Robin Michael Van Eck; Thijs Jan Burger; Astrid Vellinga; Frederike Schirmbeck; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

3.  Beck Hopelessness Scale: exploring its dimensionality in patients with schizophrenia.

Authors:  Yu-Chen Kao; Yia-Ping Liu; Chien-Wen Lu
Journal:  Psychiatr Q       Date:  2012-06

4.  Development and initial validation of Perceived Rehabilitation Needs Questionnaire for people with schizophrenia.

Authors:  Alvin H H Wong; Hector W H Tsang; Sally M Y Li; Kelvin M T Fung; Raymond C K Chung; Ada Y Leung; Michael G C Yiu
Journal:  Qual Life Res       Date:  2010-10-21       Impact factor: 4.147

5.  The relationship between hope, housing type, and housing characteristics among individuals with dual diagnoses.

Authors:  Jack Tsai
Journal:  J Dual Diagn       Date:  2010-04-02

6.  A stress-coping model of mental illness stigma: II. Emotional stress responses, coping behavior and outcome.

Authors:  Nicolas Rüsch; Patrick W Corrigan; Karina Powell; Anita Rajah; Manfred Olschewski; Sandra Wilkniss; Karen Batia
Journal:  Schizophr Res       Date:  2009-02-23       Impact factor: 4.939

7.  The Role of Metacognitive Self-Reflectivity in Emotional Awareness and Subjective Indices of Recovery in Schizophrenia.

Authors:  Kelsey A Bonfils; Lauren Luther; Sunita George; Kelly D Buck; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2016-12       Impact factor: 2.254

8.  Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions.

Authors:  Gabriel Gerlinger; Marta Hauser; Marc De Hert; Kathleen Lacluyse; Martien Wampers; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

9.  Stigmatization as an environmental risk in schizophrenia: a user perspective.

Authors:  Catherine van Zelst
Journal:  Schizophr Bull       Date:  2009-01-20       Impact factor: 9.306

10.  Internalized stigma and quality of life among persons with severe mental illness: the mediating roles of self-esteem and hope.

Authors:  Michal Mashiach-Eizenberg; Ilanit Hasson-Ohayon; Philip T Yanos; Paul H Lysaker; David Roe
Journal:  Psychiatry Res       Date:  2013-04-06       Impact factor: 3.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.